Ticker Details
Aligos Therapeutics, Inc.
IPO Date:	October 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$49.29M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 4.41%
Avg Daily Range (30 D):	$0.54 | 5.31%
Avg Daily Range (90 D):	$0.43 | 4.60%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	84
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	103
Avg Institutional Trade:	$2.37M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.3M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.69M
Avg Closing Volume:	13.54K

News

Dec 12, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi

Nov 14, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi

May 16, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: N/A

Mar 14, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Aligos Therapeutics, Inc.

Mar 3, 2025 @ 1:00 PM Aligos Therapeutics to Announce 4th Quarter 2024 F... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-12.55	$-3.04	$-1.53
Diluted EPS	$-19.78	$-3.04	$-1.53
Revenue	$2.62M	$.74M	$.97M
Gross Profit
Net Income / Loss	$-86.46M	$-31.54M	$-15.86M
Operating Income / Loss	$-86.73M	$-28.36M	$-18.57M
Cost of Revenue
Net Cash Flow	$6.62M	$23.29M	$-55.1M
PE Ratio

Splits
Aug 19, 2024	1:25